SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 129.48 |
| Enterprise Value ($M) | 121.26 |
| Book Value ($M) | -5.17 |
| Book Value / Share | -0.19 |
| Price / Book | -25.04 |
| NCAV ($M) | -6.13 |
| NCAV / Share | -0.22 |
| Price / NCAV | -21.13 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.04 |
| Return on Assets (ROA) | -0.06 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.64 |
| Current Ratio | 7.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 57.97 |
| Assets | 58.92 |
| Liabilities | 64.09 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | DG Capital Management, LLC | 5.50 | 7.47 | |
| 13G | Solas Capital Management, LLC | 5.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 55,092 | 359,580 | 15.32 | |
| 30,632 | 200,239 | 15.30 | |
| 40,797 | 172,929 | 23.59 | |
| 30,776 | 133,611 | 23.03 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EYEN – Eyenovia, Inc. | FBIO – Fortress Biotech, Inc. |
| FBRX – Forte Biosciences, Inc. | FLGC – Flora Growth Corp. |
| FTLF – FitLife Brands, Inc. |
Financial data and stock pages provided by
Fintel.io